Gabapentin
- Product NDC
- 33261-048
- 11-digit product format
- 332610048
- Labeler code
- 33261
- Product ID
- 33261-048_aeb1540b-a797-44b1-9964-28ddfba18b4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA078428
- Marketing category
- ANDA
- Marketing start
- 2009-11-24
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 33261-048-00 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-20 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-21 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-45 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-81 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-97 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
| 33261-048-99 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87f7-f424-e053-dadaa90a57ce | Gabapentin Capsules, USP |
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 33261-048 | GABAPENTIN CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 3 | Legacy NDC, 12 package rows | 20120927_cd2d3b9d-09cc-4342-9888-9b2e792a51ee.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 33261-048-00 | 33261004800 | 100 in 1 BOTTLE | Historical |
| 33261-048-02 | 33261004802 | 120 in 1 BOTTLE | Historical |
| 33261-048-10 | 33261004810 | 10 in 1 BOTTLE | Historical |
| 33261-048-20 | 33261004820 | 20 in 1 BOTTLE | Historical |
| 33261-048-21 | 33261004821 | 21 in 1 BOTTLE | Historical |
| 33261-048-30 | 33261004830 | 30 in 1 BOTTLE | Historical |
| 33261-048-45 | 33261004845 | 45 in 1 BOTTLE | Historical |
| 33261-048-60 | 33261004860 | 60 in 1 BOTTLE | Historical |
| 33261-048-81 | 33261004881 | 81 in 1 BOTTLE | Historical |
| 33261-048-90 | 33261004890 | 90 in 1 BOTTLE | Historical |
| 33261-048-97 | 33261004897 | 126 in 1 BOTTLE | Historical |
| 33261-048-99 | 33261004899 | 180 in 1 CAPSULE | Historical |